BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23232659)

  • 1. [Small renal cell carcinomas and synchronous metastases].
    Gudjonsson PS; Mariusdottir E; Palsdottir HB; Einarsson GV; Jonsson E; Petursdottir V; Hardarson S; Sigurdsson MI; Gudbjartsson T
    Laeknabladid; 2012 Nov; 98(11):585-9. PubMed ID: 23232659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
    Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
    Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005].
    Jonsson A; Hardarson S; Petursdottir V; Palsdottir HB; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 Dec; 94(12):807-12. PubMed ID: 19182316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study.
    Palsdottir HB; Hardarson S; Petursdottir V; Jonsson A; Jonsson E; Sigurdsson MI; Einarsson GV; Gudbjartsson T
    J Urol; 2012 Jan; 187(1):48-53. PubMed ID: 22088336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of metastasis for T1a renal cell carcinoma.
    Lee H; Lee JK; Kim K; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK
    World J Urol; 2016 Apr; 34(4):553-9. PubMed ID: 26245747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study.
    Ingimarsson JP; Sigurdsson MI; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
    BMC Urol; 2014 Aug; 14():72. PubMed ID: 25174263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.
    Gudbjartsson T; Thoroddsen A; Petursdottir V; Hardarson S; Magnusson J; Einarsson GV
    Urology; 2005 Dec; 66(6):1186-91. PubMed ID: 16360438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
    Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous pulmonary metastases from renal cell carcinoma--a whole nation study on prevalence and potential resectability.
    Oddsson SJ; Hardarson S; Petursdottir V; Jonsson E; Sigurdsson MI; Einarsson GV; Pfannschmidt J; Gudbjartsson T
    Scand J Surg; 2012; 101(3):160-5. PubMed ID: 22968238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based analysis of survival and incidental diagnosing of renal cell carcinoma patients in Iceland, 1971-1990.
    Gudbjartsson T; Einarsson GV; Magnússon J
    Scand J Urol Nephrol; 1996 Dec; 30(6):451-5. PubMed ID: 9008024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.
    Thoroddsen A; Einarsson GV; Hardarson S; Petursdottir V; Magnusson J; Jonsson E; Gudbjartsson T
    Scand J Urol Nephrol; 2008; 42(2):121-5. PubMed ID: 18365922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
    Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
    Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
    Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
    Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of metastases in renal cell carcinoma: a single institution study.
    Sivaramakrishna B; Gupta NP; Wadhwa P; Hemal AK; Dogra PN; Seth A; Aron M; Kumar R
    Indian J Cancer; 2005; 42(4):173-7. PubMed ID: 16391434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.